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Abstract 
In the intestine, rare neuroendocrine epithelial cells secrete hormones that aid the 
digestive process and modulate the immune response. Gastrointestinal neuroendocrine tumors 
(GI-NETs) are slow growing and comprised of cells that look similar to neuroendocrine cells. 
The Magness Lab has found that a subset of transit-amplifying (TA) cells found in the crypts of 
the small intestine have a gene expression signature with features of both stem and 
neuroendocrine cells. We hypothesize that oncogenic mutation(s) occurring in intestinal stem 
cells (ISCs) and/or TA cells keep endocrine progenitor cells derived from ISCs from exiting the 
cell cycle and fully differentiating. There is currently limited experimental evidence on the 
specific combination of mutations needed to induce GI-NET formation. However, human GI-
NETs have been found to express a loss of function in the tumor suppressor MEN1 (Multiple 
Endocrine Neoplasia Type I) and high levels of SOX4 (Sry-Box 4), a transcription factor that 
promotes endocrine differentiation. This thesis investigated whether a MEN1 loss of function 
mutation alone drove NET phenotypes in human ISCs and progenitor cells. CRISPR-Cas9 gene 
editing was utilized to introduce the loss of function mutation in the MEN1 gene. MEN1+/- cells 
were characterized for GI-NET phenotypes, including an increase in endocrine marker ChgA and 
persistent proliferation despite the progression to a more differentiated enteroendocrine cell 
phenotype. The results showed that a MEN1+/- mutation is insufficient for increased proliferation 
or increased incidence of enteroendocrine differentiation. Future studies will involve testing cells 
with homozygous MEN1 mutations, SOX4 overexpression, and the combination of MEN1 and 
SOX4 mutations for signs of GI-NET formation. If successful, these studies will provide the first 
functional evidence for GI-NET driver mutations. 
 
Background and Significance 
Intestinal Biology 
         The small intestine is responsible for most digestion and absorption of nutrients and 
minerals. The organ can be divided into three sections, the duodenum, jejunum, and ileum. The 
first segment of the small intestine, the duodenum, is about 25 cm long, and can be further 
divided into the superior, descending, 
horizontal and ascending duodenum. The 
duodenum starts at the pyloric sphincter 
and moves behind the perineum before 
curving around the pancreas and moving 
back into the peritoneal cavity to connect 
to the jejunum. The jejunum is 
approximately 90 cm long and connects 
the duodenum to the ileum, the longest segment of the small intestine. This 1.8 meter segment is 
thicker and more vascular than the jejunum, and connects to the cecum of the large intestine at 
the ileocecal sphincter. The mesentery connects both the jejunum and ileum to the posterior wall 
of the abdomen1. 
         Four distinct tissue layers constitute the small intestine: the serosa, the muscularis, the 
submucosa, and the mucosa. The innermost layer of the intestine, the mucosa, is a mucous 
membrane that consists of villi and crypts. Villi are finger-like projections into the lumen of the 
intestine. They are semi-permeable and serve to increase the surface area available for 
absorption2. Each villus consists of a monolayer of various epithelial cells, including enterocytes, 
goblet cells and enteroendocrine cells. Enterocytes make up more than 80% of the epithelial 
cells, and are responsible for the absorption of nutrients. They contain a “brush border” 
comprised of microvilli that further increase the surface area of the intestine. Goblet cells 
produce mucins for protection as well as growth and repair of the epithelium3. Finally, 
enteroendocrine cells are responsible for secreting peptide hormones to regulate glucose 
homeostasis, food intake, and gastric emptying4. 
         Between the villi are intestinal glands, known as crypts, that extend away from the 
lumen. Crypts consist of stem and progenitor 
cells, as well as Paneth cells. The 
undifferentiated stem and progenitor cells 
help to restore the differentiated pool of 
epithelial cells. As they differentiate, they 
migrate upwards into the villi, with the 
exception of Paneth cells. Paneth cells, which 
secrete antimicrobial peptides, digestive 
enzymes and growth factors, remain at the 
base of the crypt3. 
 
Neuroendocrine Tumors 
         Neuroendocrine cells receive signals from the nervous system and synthesize and release 
hormones in response. They are diffusely distributed throughout the body. The enteroendocrine 
cells of the gastrointestinal tract are a type of neuroendocrine cell. Gastrointestinal 
neuroendocrine tumors (GI-NETs) are composed of cells that look similar to neuroendocrine 
cells in that they are packed with hormones. These tumors, while slow growing, are rarely 
diagnosed (or misdiagnosed) before developing into a rather aggressive metastasis. Symptoms of 
GI-NETs, if present, may include diarrhea, constipation, abdominal pain, heart palpitations and 
others. Over 12,000 people are diagnosed with neuroendocrine cancer each year, and this number 
is increasing annually by more than five percent16. The five-year survival rate for GI-NETs is 
only about 52-77%17. This thesis aims to understand the biological mechanisms behind the onset 
of neuroendocrine tumors in the small intestine to aid the development of treatments for GI-
NETs. 
 
Intestinal Stem Cells (ISCs) 
         The stem cells of the small intestine are able to self-renew or differentiate into the many 
types of mature cells in the intestinal epithelium. ISCs reside in stem cell niches, specific 
locations that allow for their renewal and regulation. Stem cell division and differentiation allow 
the epithelial lining to be regenerated every four to five days. In this process, the stem cells first 
undergo asymmetric division to give rise to transit amplifying (TA) cells, a type of progenitor 
cell. These TA cells move upward along the crypt and into the villus as they differentiate into a 
mature cell type (with the exception of the Paneth cell, which remains at the base of the crypt 
even after differentiation). The Magness Lab has produced experimental evidence that a subset 
of TA cells in the crypts of the small intestine have a gene expression signature with features of 
both stem and neuroendocrine cells. It is therefore reasonable to hypothesize that oncogenic 
mutations undergone in intestinal stem cells (ISCs) and/or TA cells prevent endocrine progenitor 
cells derived from ISCs from exiting the cell cycle and fully differentiating, therefore leading to 
GI-NET formation. 
  
 
         Currently, there is little experimental evidence on the specific set of mutations that induce 
GI-NET formation. However, two genes, MEN1 (Multiple Endocrine Neoplasia Type 1) and 
SOX4 (Sry-Box 4) are known to have properties that make them likely candidates of promoting 
GI-NET formation when mutated.  
 
 MEN1 
         MEN1 encodes a protein known as menin. Menin serves as a tumor suppressor; it aids in 
copying and repairing DNA as well as regulating apoptosis6. A loss of function in MEN1 has 
been observed in human GI-NETs. 
 
SOX4 
         SOX4 is a member of the Sox-family of transcription factors that play powerful roles in 
early cell fate decisions18. The protein encoded by this gene may serve as a transcriptional 
regulator as well as play a role in the apoptosis pathway. SOX4 marks a progenitor cell type and 
is known to promote endocrine cell differentiation in the small intestine5. SOX4 has been found 
to be highly upregulated in human GI-NETs. 
          
Experimental Goal 
The purpose of this experiment was to induce a loss of function mutation in MEN1 and 
test the resulting cells for signs of GI-NET formation, including increased proliferation and 
increased incidence in Chromogranin A (ChgA), a GI-NET marker. The effects of SOX4 
overexpression will be explored as a part of future experiments. 
 
CRISPR-Cas9 
Inducing a loss of function in the MEN1 gene involves utilization of the CRISPR-Cas9 
system. The components of this system include the Cas9 endonuclease and a single guide RNA 
(sgRNA). The sgRNA consists of a 20 nucleotide crRNA sequence that is complementary to the 
gene of interest as well as a tracrRNA that interacts with the Cas9 protein. The sgRNA (or 
gRNA) first leads Cas9 to the targeted locus of the genome. The gRNA then binds to the DNA at 
the target site while Cas9 recognizes and binds to a protospacer adjacent motif (PAM) sequence 
located downstream of the target sequence. This PAM sequence is of the NRG form, where N 
represents any of the four bases, while R represents either A or G. Cas9 recognizes the sequence 
NGG more effectively than it recognizes the sequence NAG13,26.  
Once the Cas9/gRNA complex is bound to the DNA, Cas9 generates a double stranded 
break at the target site that is then repaired using either non-homologous end joining (NHEJ) or 
homology-directed repair (HDR) if a DNA template is provided. NHEJ is the predominant repair 
pathway and is prone to insertion and deletion (indel) mutations13. Therefore, this mechanism 
can be used to induce a loss of function mutation in a gene of interest.  
 
 
Materials and Methods 
Retrieval of Human Intestinal Stem Cells 
Intestinal stem cells were retrieved from the duodenum of an anonymous human donor. 
Segments of the donor intestine were cut longitudinally and transversely to expose the 
epithelium, and then stored in DPBS. The tissue was lightly shaken to remove debris and feces. 
The intestinal pieces were added to conical tubes containing 30 mL of colon isolation buffer. The 
tube was manually shaken to remove additional mucus and debris. This process was repeated 
until the isolation buffer appeared clear after shaking. The tissue was then added to a 30 mL 
solution containing colon isolation buffer, EDTA and DTT for thirty minutes at room 
temperature. The tubes were shaken by hand with moderate force for two minutes and placed on 
ice immediately after. This process served to extract the villi into the solution. The tissue was 
then transferred to a new tube containing colon isolation buffer, EDTA and DTT. The tube was 
placed on a rocker at room temperature for ten minutes and then shaken for two minutes to 
extract the crypts into the solution. The tissue was transferred once again to a new tube 
containing isolation buffer, EDTA and DTT and rocked at room temperature for ten minutes. 
The solution was shaken a third time to release more crypts, transferred to a new tube and shaken 
one last time to release any remaining crypts. Isolated crypts (from shakes 2 and 3) were pooled 
into a new tube and centrifuged at 600 g for one minute.  
The crypts were resuspended in expansion media (EM) and Y-27632 (or Y-27). Media 
containing about 15,000 crypts was transferred to a new tube and centrifuged at 600 g for one 
minute. The cells were then resuspended in 12 mL of EM and 10 µM of Y-27. Finally, the cells 
were plated in a 6-well expansion plate (4 mL per well).  
 
Cell Culture Medium 
The expansion medium used to culture the human intestinal stem cells (hISCs) consists of 
the following components: basal culture medium, EGF, noggin, R-spondin, Wnt3A, 
nicotinamide, gastrin and SB20219011. Y-27 is added to the media any time the cells are 
dissociated and plated. Y-27 is a cell-permeable, selective inhibitor of Rho-associated, coiled-
coil containing protein kinase (ROCK). It serves to prevent anoikis, or dissociation-induced 
apoptosis, when cells are broken down into single cells, thereby enhancing the survival of the 
hISC monolayers12. 
 
Selection of gRNA Target Sites for MEN1 Knockout 
A loss of function was induced in the MEN1 gene using CRISPR-Cas9. The process 
began with selection of the gRNA target sites that Cas9 would cleave at in the MEN1 gene. 
CCTop (CRISPR-Cas9 target online predictor) was 
used to select the gRNA target sites. The MEN1 exon 
sequence was input into the program, along with the 
desired PAM sequence, NGG. A list of possible target 
sequences was generated, along with a list of potential 
off-target sites. To reduce the possibility that Cas9 
would cleave at an incorrect locus in the genome, 
target sequences were chosen based on the criteria that 
the off-target sequences should have at least three 
mismatches from the target sequence. Three gRNA 
targets (denoted as T1, T2 and T10) were selected. 
           
Transfection of hISCs with CRISPR-Cas9 Tools 
         The hISCs were transfected with the Cas9 protein and gRNAs associated with the 
selected MEN1 targets: T1, T2, and T10. Y-27 was added to the cells two hours prior to the 
transfection procedure. To prepare the gRNA mix containing both the gRNA and the tracer RNA 
(tracRNA), gRNAs and tracRNAs from IDT were first resuspended in nuclease-free annealing 
buffer. 5 µL of each of the three gRNAs was mixed with 5 µL of the tracRNA and annealed. 
Cas9/gRNA mixes were prepared by adding 1 µL of the IDT Cas9 nuclease with 1 µL of each of 
the annealed gRNA/tracRNA mixes. The Cas9/gRNA mixes were incubated at room temperature 
for five minutes and placed on ice. For the positive control, pMaxGFP was used as it 
constitutively expresses GFP. The annealing buffer served as the negative control. 
         Nucleofection was performed using the Lonza 4D Nucleofection system. The 
nucleofection solution was prepared by mixing 16.4 µL of buffer P1 with 3.6 µL of supplement 1 
per reaction. The cells were then dissociated. Collagenase IV (500 units/mL final concentration) 
was first used to digest the collagen in the wells containing the wild type hISC populations. 
Conditioned media (containing old media from the wells) was set aside as well. The solution 
containing the cells and collagenase was spun down at 1000 g for five minutes at room 
temperature. The media was removed, and the cells were resuspended in PBS. Once the cells 
were repelleted and the PBS was removed, the cells were resuspended in 500 µL of prewarmed 
TrypLE with Collagenase IV (500 units/mL final concentration) and incubated for five minutes. 
The cells were passed through an insulin syringe to be dissociated into single cells. TrypLE was 
then neutralized with media and the solution was spun down at the conditions listed previously. 
The cells were rinsed with PBS once again and then resuspended in nucleofection solution P1 
and supplement. The solution was divided into aliquots to allow for multiple experimental 
conditions and incubated for five minutes at room temperature. The cells, except for the negative 
control, were then nucleofected (EN150 nucleofector program) and incubated for ten minutes at 
room temperature. Finally, the cells were resuspended in 3 mL of conditioned medium and 3 µL 
of Y-27 and plated on a collagen scaffold.   
 Assaying for CRISPR activity 
Transfection of the Cas9 protein and gRNAs into the hISCs was confirmed using a T7 
endonuclease assay. T7 endonuclease is an enzyme that cleaves heteroduplexes, or bulges in the 
DNA that form due to mismatches in the nucleotides.  
 The genomic DNA was first extracted from the cells. This was done by dissociating and 
pelleting the cells using the standard single cell dissociation procedure (mentioned in the “Single 
Cell Dissociaton” section). The cells were resuspended in 500 µL of proteinase K solution 
(containing 10 mg/mL proteinase K diluted 1:10 in buffer TE) and incubated overnight at 55 °C. 
The DNA was then purified with a 1:1 phenol/chloroform extraction.  
 The purified DNA was then PCR amplified. A sample of each PCR product (10 µL) was 
combined with NEB Buffer (2 µL) and molecular grade water (7 µL). Each solution was added 
to the thermal cycler, and the temperature was ramped down from 95 °C to room temperature to 
denature and slow cool the DNA. This process would allow the positive and negative DNA 
strands to separate and re-ligate with arbitrary complementary strands in the mixture. Since the 
mutations made during NHEJ are distinct among the different DNA molecules, ligation between 
the DNA strands would result in mismatches at the target site, therefore leading to the formation 
of heteroduplexes. Ten units of T7 endonuclease (1 µL) were added to each solution, allowing 
the enzyme to recognize and cleave the heteroduplex DNA. The samples were then incubated at 
37 °C for an hour. Next, the samples underwent gel electrophoresis; the presence of two bands 
would indicate that the DNA molecules were successfully cleaved by T7 endonuclease and 
contained the loss of function mutation. A TIDE (Tracking of Indels by Decomposition) analysis 
was also completed using the chromatograms for the control and test samples to quantify the 
percentage of MEN1 knockout for each of the targeted hISC populations. 
 
Single Cell Dissociation 
  The T1 and T10 cell populations, which were found to contain editing based on the T7 
endonuclease assay, were dissociated into single cells and allowed to grow into individual 
colonies consisting of genetically identical cells. This allows for isolation of the colonies and 
subsequent sequencing of the cells to determine their genotype.  
The single cell dissociation was performed by digesting the collagen scaffold in culture 
medium containing 500 units/mL Collagenase IV. The solution was spun down at 1000 g for five 
minutes at room temperature to obtain a cell pellet. Following an intermediate PBS wash and an 
additional spin at the same conditions, a 500 uL solution containing TrypLE and 500 units/mL 
Collagenase IV was used to digest intracellular adhesion molecules in the cells and remove any 
remaining collagen. The cells were passed through a 28-gauge insulin needle six times to 
mechanically dissociate the cells into single cells. TrypLE was then neutralized with 4.5 mL of 
EM and the solution was spun down at 600 g for five minutes at room temperature. The cells 
were then resuspended in 1 mL EM. A hemocytometer was used to determine the total number 
of cells in the 1 mL sample, and the cells were then plated at 500 cells per well for the T1 
population and 1500 cells per well for the T10 population. The cells were plated at different 
densities in order to determine the optimum density for clonal isolation.  
 To increase the chance of obtaining a clone with a MEN1 double allele knockout, more 
of the T10 population (which contained the greatest amount of editing according to the TIDE 
analysis mentioned in the “Results” section) was thawed and plated. After reaching about 70% 
confluency, the T10 cell population was passaged 1:3 in a 6-well plate. The cells were permitted 
to grow to about 70% confluency once again. Two of the wells were frozen, while one of the 
wells was dissociated into single cells using the procedure mentioned above. The well was found 
to contain greater than one million cells which were then plated at densities ranging from 
approximately 63,000 cells per well to over 500,000 cells per well in a 6-well plate.   
The cells were monitored and fed over the next few days. The well containing more than 
500,000 cells was observed to have too high of a density for picking individual colonies. Four 
days after plating, the single cell dissociation procedure was carried out again on the well 
containing more than 500,000 cells. This time, the cells were plated at the following densities in 
a 6-well plate: 5000, 10000, 25000, 50000, 75000, and 100,000 cells per well.  
 
Isolation of Clones 
The clones were ready to be isolated when the wells contained around 10+ clones with 
clonal widths ranging between 300 - 400 µm. To isolate the clones, 300 µL of 5000 units/mL 
Collagenase IV was first added to the well of interest. The cells were then incubated for twenty 
minutes to digest the collagen. This released the colonies from the collagen scaffold without 
dissociating them. The colonies were transferred to another tube and centrifuged at 600 g for five 
minutes. The colonies were then resuspended in 5 mL of PBS and added to a ten-centimeter 
plate. Free in the PBS, the colonies could then be easily extracted with a pipette and placed into a 
96-well plate containing medium and Y-27. One colony was placed in each well.   
 
  
Analysis of Isolated Clones 
 
 
 
The colonies were allowed to grow to about 30% confluency and then passaged to a 24-
well plate. This procedure first involved adding a 50 µL 1:1 collagenase (2500 units/mL final 
concentration):media mix to each well that would be passaged and manually dislodging the 
outside of the collagen patty from the plate. The cells were then incubated at 37 °C for ten 
minutes. The media and partially digested collagen were then transferred to a separate tube, and 
a pipette was used to break up the collagen. The tubes were incubated in a 37 °C water bath for 
five minutes to digest the remaining collagen. The tubes were centrifuged at approximately 1000 
g for five minutes, and the supernatant was discarded. The cell pellet was resuspended in 50 µL 
of TrypLE and incubated at 37 °C for five minutes. The cells were then broken up by pipetting 
the solution about fifteen times.  
A small sample each cell suspension (5 µL) was transferred to a PCR tube, along with 1 
µL of 10 mg/mL proteinase K and 4 µL of Buffer TE. These 10 µL solutions were run in a 
thermal cycler at 50 °C for ten minutes, 94 °C for ten minutes, and held at 15 °C overnight.  
The remaining cells in the TrypLE suspensions were neutralized with 450 µL of media 
per suspension. The tubes were centrifuged at approximately 1000 g for five minutes, and the 
supernatant was discarded. The cells were then resuspended in 1 mL EM and 1 µL Y27 per well 
in a 24-well pre-rinsed collagen plate.  
The 10 µL solutions containing the extracted DNA were then prepared to be sequenced in 
order to determine the type of MEN1 mutation in the clonal population. Overall, 8 T1 clones and 
34 T10 clones were tested. A sample of each solution (4 µL) was mixed with 1 µL of each of the 
forward and reverse MEN1 primers diluted 1:10, 25 µL of PCR mastermix (Apex Hot Start Taq 
BLUE Mastermix) and 19 µL of molecular grade water to bring the total sample volume to 50 
µL. The DNA samples were then amplified and loaded on to the gel to check for the presence of 
bands. The samples were sequenced to determine the type of MEN1 mutation. 
 
Staining for Chromogranin A  
Chromogranin A (ChgA) is a protein secreted by neuroendocrine cells. Since stem cells 
are not expected to secrete ChgA, the protein can serve as a GI-NET marker. In this experiment, 
a wild type and MEN1+/- colony was therefore each stained for the presence of ChgA, with the 
wild type population representing the control.  
 The staining process involved the use of a rabbit-derived primary antibody that is specific 
to ChgA, and a goat-derived, anti-rabbit secondary antibody that is specific to any rabbit protein. 
The secondary antibody also contained a fluorophore to allow for visualization. To begin the 
staining process, the cells were washed with PBS. Paraformaldehyde (PFA) was then added to 
the cells, and the cells were incubated at room temperature for twenty minutes. The PFA was 
removed, and the cells were washed twice with 3% BSA. The cells were then washed with PBS 
for fifteen minutes, and subsequently washed with 0.1% PBST for ten minutes. 0.3% PBST was 
then used to permeabilize the cells for fifteen minutes. A 1X Cell Signaling Blocking reagent (3 
mL) was then added to the cells for thirty minutes. The blocking solution would serve to reduce 
nonspecific binding of the antibody14. The 1X blocking solution was then removed from the 
cells, and the primary antibody, diluted in 1X blocking solution 1:200, was added to the cells. 
The MEN1+/- colony was then incubated at room temperature for two hours, while the wild type 
colony was incubated at 4 °C overnight. 
 The cells were then washed with 0.1% PBST for fifteen minutes. The PBST was 
removed, and the secondary antibody, diluted in the 1X blocking reagent 1:200, was added to the 
cells. The cells were incubated at room temperature for one hour. The cells were then washed 
with 0.1% PBST (3 mL) for fifteen minutes and PBS for five minutes. Bisbendzimide, diluted at 
1:5000 in PBS for the MEN1+/- colony and diluted at 1:2500 in PBS for the wild type colony, 
was then used to stain the cells for five minutes. Finally, the cells were washed twice with PBS, 
with five minutes in between washes.  
 
Staining for EdU 
EdU (5-ethynyl-2’-deoxyuridine) is a thymidine analog and can serve as an S-phase 
marker to quantify cell proliferation. The molecule is incorporated into DNA during the DNA 
replication stage of the cell cycle. A fluorescent azide that covalently cross-links to the EdU 
molecule must be added to the sample to allow for visualization of the EdU marker15. In this 
experiment, a wild type and MEN1+/- cell population was each stained for EdU to measure and 
compare the amount of cell proliferation between the two genotypes. 
Approximately three hours prior to the start of the procedure, fresh EM (3 mL) 
containing EdU (3 µL) was added to the cells. After the three hours, the media was replaced with 
4% PFA. The cells were then incubated at room temperature for twenty minutes. The PFA 
solution was then removed, and the cells were washed twice with 3% BSA in PBS for five 
minutes per wash. This was followed by the addition of 0.5% Triton X-100 in PBS to the cells. 
The cells were incubated for another twenty minutes. The cells were then washed twice with 3% 
BSA for five minutes per wash. An EdU staining solution containing 76% EdU reaction buffer, 
4% CuSO4, 2.5% Sulfo-CY5 azide and 20% EdU reaction buffer additive (L-aspartic acid) was 
then added to the cells. The cells were incubated at room temperature for an hour, away from any 
light. After the hour, the EdU staining solution was removed, and the cells were rinsed with PBS 
for five minutes.  
 Hoechst 33342 (diluted 1:1000 in PBS) is a Bisbendzimide used for nuclear staining. The 
diluted sample (3 mL) of the dye was added to the cells, which were then incubated for five 
minutes, away from any light. Finally, the cells were washed twice with PBS for five minutes per 
wash. The cells were covered and stored at 4 °C for four days. 
 
Results 
Analysis of Transfected Cell Populations 
A T7 endonuclease assay was used to verify that the transfection of Cas9 and the MEN1-
targeting gRNAs was successful. The gel electrophoresis results from this assay showed two 
bands for the T1 and T10 populations. No bands were visible for the T2 population. This 
indicates that the T1 and T10 populations contained significantly more editing of the MEN1 gene 
than did the T2 population. 
 
 
 
 
 
 
 
 
 
 
 
 
To quantify the percentage of editing in the cell populations, a TIDE (Tracking of Indels 
by Decomposition) analysis was completed. After the transfection, the DNA from the control 
sample (wild type) and the three test samples (T1, T2 and T10) were sequenced to obtain a 
chromatogram for each of the samples. The chromatogram for the control sample and each of the 
test samples was then input into the TIDE program (https://tide.deskgen.com). The program 
compares the amount of noise in an experimental sequencing sample to a wild type control 
sample and calculates the percentage of each type of indel mutation. (Table 1). The T10 cell 
population, with 59.4% MEN1 knockout, contained the most editing out of the three cell 
populations. 
  
 
  
Cell population %  knockout R2 
T1 12.5 0.99 
T2 4.9 0.99 
T10 59.4 0.98 
 
 
 
Analysis of Isolated Clones  
Sanger sequencing was used to sequence the MEN1 gene in the DNA samples of each of 
the isolated clones. The nucleotide sequence for each clone was compared to the wild type 
sequence. Manual comparison between the wild type and test sample sequences allowed for the 
determination of the number of wild type, MEN1+/- and MEN1-/- colonies. Out of the 34 T10 test 
samples, 6 were wild type (two wild type alleles), 17 were heterozygous for the MEN1 mutation 
(one wild type allele and one mutant allele), and 1 was homozygous for the MEN1 mutation (two 
mutant alleles). The remaining samples either contained multiple clones or had unclear 
sequencing results. 
 
 
 
Table 1. Percentage of MEN1 knockout in each targeted cell 
population. The T10 population contained the greatest amount 
of editing. 
  
 
 
 
 
 
 
 
ChgA Staining Results 
 
 
The wild type and MEN1+/- colonies that were stained for ChgA were imaged one day 
after the staining procedure. The FITC setting of the microscope (fluorescence emission 
wavelength of 518 nm) allowed for visualization of locations of ChgA, indicated by a bright 
green pigment. Visual comparison between the wild type and MEN1+/- images showed no 
significant difference in the amount of ChgA. Any presence of ChgA in the wild type colony 
most likely indicated the presence of differentiated enteroendocrine cells in culture (Figure 11).  
 
 
 
 
 
 
EdU Staining Results 
 
The wild type and MEN1+/- hISCs that were stained for EdU to mark the proliferative 
cells. They were imaged four days after the staining process. The cells were observed under the 
far-red setting of the microscope (fluorescence emission of 691 nm). Red pigmentation in the 
images indicates the presence of EdU. Similar to the ChgA staining results, visual comparison of 
the images showed no significant difference in the amount of EdU between the wild type and 
MEN1+/- colonies. This indicates that the rate of proliferation is not significantly different 
between wild type cells and those with a heterozygous MEN1 mutation.  
 
 
 
 
 
 
 
Discussion 
Until recently, culturing primary intestinal epithelial cells was a challenge due to cells’ 
lack of proliferation when they were placed in culture. Researchers alternatively needed to use 
cancer cell lines as these cells were able to effectively proliferate as confluent monolayers. 
However, the cell lines varied greatly in phenotype from normal epithelium, therefore 
introducing uncertainties in their ability to accurately represent healthy intestinal form and 
function. To combat this problem, 3D organoid culture was recently introduced. This culture 
system allows for the maintenance of a stem cell niche as well as differentiation of the stem cells 
into mature cell types, mimicking the native villus-crypt structure present in the normal human 
intestine24. However, studies on intestinal stem cells are a challenge with 3D organoids because 
the organoid’s enclosed architecture limits access to the lumen of the organoid.  
Wang et. al determined culture conditions that allowed for 2D culture of primary human 
rectal epithelial cell monolayers on collagen hydrogel.19 2D cultures are beneficial because the 
cells are exposed and easily accessible for experimental manipulation. For this reason, our 
experiment utilized 2D culture techniques to effectively culture stem and progenitor cells from 
the small intestine. Additionally, our experiment utilized novel methods of single cell 
dissociation, clonal isolation, and transfection that have previously not been accomplished with 
2D hISC monolayers. While 2D culture provides numerous benefits in terms of access to the 
luminal compartment, flat cultures are not as representative of in-vivo intestinal structures as are 
3D organoids. However, further experimentation would need to be done to determine any 
significant functional differences between stem cells grown in 2D culture versus those grown in 
3D culture. 
In this experiment, Cas9 and the gRNAs were delivered by directly transfecting the 
hISCs with the Cas9 protein in complex with the gRNA22. This is a higher-throughput approach 
than transfecting a plasmid, which results in delayed expression and continuous generation of the 
Cas9 protein, therefore increasing the chance of off-target mutations and lowering editing 
efficiency23. Therefore, direct transfection of the Cas9 protein and gRNAs was the preferred 
method as it increased overall transfection efficiency, as indicated by the 60% transfection 
efficiency achieved in the T10 population (which is twice as high as the highest recorded 
transfection efficiency prior to this experiment).20  
Single cell dissociation of the hISCs provided an effective way to isolate single colonies 
consisting of genetically identical cells. The process was done three times, each at different 
ranges of densities, in order to determine the ideal density for isolation of colonies. When the 
cells were plated at too low of a density, the colonies grew very slowly and could not be picked 
until several weeks later. On the other hand, colonies plated at too high of a density could not be 
distinguished from one other at the time of isolation. The wells containing 50,000, 75,000, and 
100,000 cells were able to be picked after the fewest number of days (9 days), while the well 
with 25,000 cells produced the most number of colonies (22 colonies). As a result, we concluded 
that the optimum density for plating hISCs in a 6-well plate for clonal isolation is between 
25,000 to 50,000 cells per well.  
The procedure for clonal isolation was determined to be the most effective in comparison 
to other attempted methods. We originally tried isolating the cells directly from the collagen 
scaffold. However, the cells remained too tightly adhered to the collagen to be isolated. We also 
tried adding TrypLE to cleave the adhesion proteins that retain the cells to the matrix. This 
method dissociated the colonies without releasing them from the collagen. Ultimately, adding 
300 µL of 5000 units/mL Collagenase IV to the cells and resuspending them in PBS before 
attempting to isolate colonies served to be a quick and simple method for isolation since the cells 
flowed freely in the PBS without dissociating. The optimum clonal size was found to be at least 
300 to 400 um in width, and was determined by testing different colonies of varying sizes. 
Colonies below this size range were observed to grow more poorly.  
  The results from the ChgA and EdU staining procedures revealed that there was no 
significant difference in the amount of ChgA or EdU between the wild type and MEN1+/- cells. 
This indicates that a heterozygous mutation in MEN1 is insufficient for increased incidence of 
enteroendocrine differentiation or increased cell proliferation, both of which are features of GI-
NETs. Experimental evidence suggests that these results were expected. According to a 2008 
study by Marini et al, mice with a heterozygous mutation in MEN1 developed endocrine tumors 
late in life while mice with a homozygous mutation in MEN1 died while still in utero. This leads 
us to believe that a homozygous MEN1 mutation (which leads to a complete loss in menin 
production) may be necessary for significant alterations in proliferative capacity or 
differentiation of the mutated cell25. 
Future experimental objectives will aim to test the MEN1-/- clone for changes in the 
expression of proliferation and enteroendocrine markers under various conditions. Since GI-
NETs have been found to contain features of both stem and enteroendocrine cells, the clones will 
be cultured in both stem and differentiation media to either look for cells that maintain stemness 
under differentiation conditions or display enteroendocrine characteristics under stem conditions. 
Specifically, we will use ChgA and EdU as markers for enteroendocrine differentiation and 
proliferative capacity, respectively. Since GI-NETs have also been found to contain upregulation 
of SOX4, a SOX4 overexpression plasmid will be transfected into the wild type, MEN1+/-, and 
MEN1-/- clones to overexpress the gene. These populations will be compared to the wild type 
cells and cells containing a MEN1 knockout alone.  
Additional genes that could potential serve as driver genes for GI-NETs will be explored 
as well. FOXA1 is one such gene with characteristics favorable for further investigation. FOXA1 
is a transcription factor that plays a role in the establishment and regulation of tissue-specific 
gene expression in differentiated tissues. It has been found to bind to compacted chromatin 
through its interactions with histones in order to open the chromatin for other proteins. FOXA1 is 
also involved in modulation of nuclear hormone receptor transcriptional activity, cell cycle 
regulation and glucose homeostasis7. FOXA1 has been prominently expressed in esophageal 
cancer, lung cancer, and 12T-10 invasive undifferentiated neuroendocrine carcinomas8. One 
study showed that miR-1290, a microRNA with high expression in colon cancer, “promotes 
gastric tumor cells proliferation and metastasis through FOXA19.” It therefore may be beneficial 
to test the overexpression of FOXA1 independently and in combination with mutations in the 
MEN1 and SOX4 genes. 
 
 
Conclusion  
 Human GI-NETs are characterized by cells resembling the enteroendocrine cells found in 
the intestinal crypts. This resemblance as well as the cells’ proliferative nature suggests that 
oncogenic mutations in intestinal stem or TA cells may prevent endocrine progenitor cells from 
exiting the cell cycle and fully differentiating into the short-lived enteroendocrine cells. MEN1, a 
tumor suppressor, and SOX4, a transcriptional regulator involved in promotion of endocrine 
differentiation serve as promising candidates for driver genes of GI-NET formation. A loss of 
function in MEN1 and an overexpression of SOX4 have been found to be present in human GI-
NETs. Therefore, this experiment first tested the effects of a MEN1+/- mutation on the 
proliferation rate and incidence of the GI-NET marker, ChgA. The procedure involved using 
CRISPR-Cas9 to induce a loss of function mutation in the MEN1 gene. This was followed by 
single cell dissociation of the targeted population, clonal isolation, and sequencing of the isolated 
clones to obtain a clonal population containing a MEN+/- mutation and a clonal population 
containing a MEN-/- mutation. The MEN+/- cells were stained for ChgA and EdU. Visual 
comparison of the staining images between the wild type and MEN+/- colonies indicated that 
there was no significant difference in the amount of either ChgA or EdU between the two 
colonies. Therefore, this indicates that a heterozygous mutation in MEN1 is insufficient for 
increased proliferation or increased incidence of endocrine differentiation. 
 The next step will be to test the MEN-/- colony for signs of GI-NET formation. 
Overexpression of SOX4 as well as mutations in other potential candidates of GI-NET driver 
genes, such as FOXA1, will be explored as well. 
By identifying driver mutations of GI-NETs, we hope to better understand the biological 
and genetic basis behind this disease, and thereby improve our ability to diagnose and treat this 
aggressive form of cancer.  
 
Acknowledgments 
I would like to thank my research advisor, Dr. Scott Magness, for the opportunity to work 
on this project and for his guidance along the way. I would also like to thank Dr. Leigh Ann 
Samsa, Keith Breau, and other fellow researchers at the Magness Lab for their support and 
contributions toward this project.  
References 
1.  OpenStax. Anatomy and Physiology. 2013 Mar 6. 
2.  The Small Intestine. Lumen. 
3.  Ensari A, Marsh MN. Exploring the villus. Gastroenterology and hepatology from bed to  
bench. 2018. 
4.  Mellitzer G, Beucher A, Lobstein V, Michel P, Robine S, Kedinger M, Gradwohl G. Loss 
of enteroendocrine cells in mice alters lipid absorption and glucose homeostasis and 
impairs postnatal survival. The Journal of Clinical Investigation. 2010 May 3. 
5.  SOX4 Gene. genecards.org.  
6.  MEN1 gene - Genetics Home Reference - NIH. U.S. National Library of Medicine.  
7.  FOXA1 Gene. genecards.org.  
8.   FOXA1. WikiGenes.  
9.      Lin M, Shi C, Lin X, Pan J, Shen S, Xu Z, Chen Q. sMicroRNA-1290 inhibits cells 
proliferation and migration by targeting FOXA1 in gastric cancer cells. ScienceDirect. 
2016 Feb 3. 
10.  Tissue-engineered Small Intestine - Oley Foundation.  
11.  Sato T, Stange DE, Ferrante M, Vries RGJ, Van Es JH, Van den Brink S, Van Houdt WJ, 
Pronk A, Van Gorp J, Siersema PD, et al. Long-term expansion of epithelial organoids 
from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. 
Gastroenterology. 2011 Nov. 
12.  Y-27632. Stemcell Technologies. 
13.  CRISPR/Cas9 & Targeted Genome Editing: New Era in Molecular Biology. New 
England Biolabs.  
14.  Preparing Fixed Cells for Labeling. Thermo Fisher Scientific - US.  
15.  EdU Assay / EdU Staining Proliferation Kit (iFluor 488) (ab219801). Abcam.  
16.  Neuroendocrine Tumor. Cancer.Net. 2014 Jun 17. 
17.  Small bowel carcinoids. What is the prognosis for small intestinal neuroendocrine 
tumors?  
18.  Gracz AD, Samsa LA, Fordham MJ, Trotier DC, Bailey Zwarycz Y-HL, Bao K, Starmer 
J, Shroyer NF, Reinhardt RL, Magness ST. Sox4 drives Atoh1-independent intestinal 
secretory differentiation toward tuft and enteroendocrine fates. bioRxiv. 2018 Jan 1. 
19.  Wang Y, DiSalvo M, Gunasekara DB, Dutton J, Proctor A, Lebhar MS, Williamson IA, 
Speer J, Howard RL, Smiddy NM, et al. Self-renewing Monolayer of Primary Colonic or 
Rectal Epithelial Cells. Cellular and molecular gastroenterology and hepatology. 2017 
Mar 6. 
20.  Fujii M, Matano M, Nanki K, Sato T. Efficient genetic engineering of human intestinal 
organoids using electroporation. Nature News. 2015 Sep 3. 
21.  Matano M, Date S, Shimokawa M, Takano A, Fujii M, Ohta Y, Watanabe T, Kanai T, 
Sato T. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human 
intestinal organoids. Nature medicine. 2015 Mar. 
22.  Hempstead A. CRISPR 101: Ribonucleoprotein (RNP) delivery. addgene blog. 2018 Sep 
6. 
23.  Farboud B, Jarvis E, Roth TL, Shin J, Corn JE, Marson A, Meyer BJ, Patel NH, 
Hochstrasser ML. Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse 
Cells and Organisms. Journal of visualized experiments : JoVE. 2018 May 25. 
24.  Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, van Es JH, 
Abo A, Kujala P, Peters PJ, et al. Single Lgr5 stem cells build crypt-villus structures in 
vitro without a mesenchymal niche. Nature. 2009 May 14. 
25.  Marini F. Multiple Endocrine Neoplasia Type 1 (MEN1) Syndrome. NCBI. 2008 Aug 9. 
26.  Zheng T, Hou Y, Zhang P, Zhang Z, Xu Y, Zhang L, Niu L, Yang Y, Liang D, Yi F, et 
al. Profiling single-guide RNA specificity reveals a mismatch sensitive core sequence. 
Scientific reports. 2017 Jan 18. 
27.  GI tract. AboutKidsHealth.  
28.  Sancho R, Cremona1 CA. Rocio Sancho. Embo reports . 2015 May 1 
29.  Introduction to the CRISPR/Cas9 system. Takara. 
 
 
 
 
 
 
 
 
 
 
